Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in japanese patients with type 2 diabetes mellitus
Conclusions Ipragliflozin may have a potential for lowering sd LDL-C levels associated with increasing LDL particle size in Japanese patients with T2DM.
Source: Journal of Clinical and Translational Endocrinology - Category: Endocrinology Source Type: research
More News: Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Statistics | Study